AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

Interim / Quarterly Report Aug 11, 2025

8725_rns_2025-08-11_36713797-cb90-414c-ac44-b9f14f4add5e.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED FINANCIAL STATEMENTS AS OF JUNE 30, 2025

CONVENIENCE TRANSLATION INTO ENGLISH OF INDEPENDENT AUDITOR'S REVIEW REPORT ORIGINALLY ISSUED IN TURKISH

REPORT ON REVIEW OF INTERIM CONDENSED FINANCIAL INFORMATION

To the General Assembly of Adel Kalemcilik Ticaret ve Sanayi A.Ş.

Introduction

We have reviewed the accompanying condensed statement of financial position of Adel Kalemcilik Ticaret ve Sanayi A.Ş. (the "Company") as at 30 June 2025 and the related condensed statements of profit or loss, other comprehensive income, changes in equity and cash flows for the six-month period then ended. The management of the Company is responsible for the preparation and fair presentation of this interim condensed financial information in accordance with Turkish Accounting Standard 34 ("TAS 34") "Interim Financial Reporting". Our responsibility is to express a conclusion on this interim condensed financial information based on our review.

Scope of review

We conducted our review in accordance with the Standard on Review Engagements ("SRE") 2410, "Review of interim financial information performed by the independent auditor of the entity". A review of interim condensed financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and the objective of which is to express an opinion on the financial statements. Consequently, a review on the interim condensed financial information does not provide assurance that the audit firm will be aware of all significant matters which would have been identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to conclude that the accompanying interim condensed financial information is not prepared, in all material respects, in accordance with TAS 34.

PwC Bağımsız Denetim ve Serbest Muhasebeci Mali Müşavirlik A.Ş.

Salim Alyanak, SMMM Independent Auditor

Istanbul, 11 August 2025

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

CONTENTS PAGE
INTERIM CONDENSED STATEMENT OF FINANCIAL POSITION 1-2
INTERIM CONDENSED STATEMENT OF PROFIT OR LOSS 3
INTERIM CONDENSED STATEMENT OF OTHER COMPREHENSIVE INCOME 4
INTERIM CONDENSED STATEMENT OF CHANGES IN EQUITY 5
INTERIM CONDENSED STATEMENT OF CASH FLOWS 6
NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS 7-48
NOTE 1 – COMPANY'S ORGANIZATON AND NATURE OF OPERATIONS 7
NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS 8-13
NOTE 3 – SEGMENT REPORTING 13
NOTE 4 – CASH AND CASH EQUIVALENTS 14
NOTE 5 – FINANCIAL INVESTMENTS 14
NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS 14-17
NOTE 7 – TRADE RECEIVABLES AND PAYABLES 18
NOTE 8 – OTHER RECEIVABLES AND PAYABLES 19
NOTE 9 – INVENTORIES 20
NOTE 10 – PROPERTY, PLANT AND EQUIPMENT 21
NOTE 11 – INTANGIBLE ASSETS 22-23
NOTE 12 – PROVISIONS, CONTINGENT ASSETS AND LIABILITIES 24-26
NOTE 13 – EMPLOYEE BENEFITS 26-27
NOTE 14 – OTHER ASSETS AND LIABILITIES 28
NOTE 15 – CAPITAL, RESERVES AND OTHER EQUITY ITEMS 29-30
NOTE 16 – REVENUE AND COST OF SALES 31
NOTE 17 – OTHER INCOME AND EXPENSES FROM OPERATING ACTIVITIES 32
NOTE 18 – INCOME AND EXPENSES FROM INVESTMENT ACTIVITIES 32-33
NOTE 19 – FINANCE INCOME AND EXPENSES 33
NOTE 20 – DEFERRED TAX ASSETS AND LIABILITIES 34-35
NOTE 21 – EARNINGS PER SHARE 36
NOTE 22 – RELATED PARTY BALANCES AND TRANSACTIONS 36-38
NOTE 23 – NATURE OF RISKS ARISING FROM FINANCIAL INSTRUMENTS 38-43
NOTE 24 – FINANCIAL INSTRUMENTS 44-46
NOTE 25 – DISCLOSURES ON NET MONETARY POSITION GAINS / (LOSSES) 47
NOTE 26 – EVENTS AFTER THE REPORTING PERIOD 48

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF FINANCIAL POSITION AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

Notes Reviewed
30 June 2025
Audited
31 December 2024
Assets
Current assets
Cash and cash equivalents 4 151.926 769.273
Trade receivables 682.793 153.083
- Trade receivables from related parties 22 43.940 49.870
- Trade receivables from third parties 7 638.853 103.213
Other receivables 3.544 1.779
- Other receivables from third parties 8 3.544 1.779
Inventories 9 1.093.872 921.064
Prepaid expenses 14 164.961 21.145
- Prepaid expenses from related parties 22 97.186 -
- Prepaid expenses from third parties 67.775 21.145
Current tax assets 14 4.694 141.995
Other current assets 72.189 82.854
- Other current assets from third parties 14 72.189 82.854
Total current assets 2.173.979 2.091.193
Non-current assets
Financial investments 5 1.491 1.523
Property, plant and equipment 10 913.567 921.599
Right of use assets 6 193.121 178.658
Intangible assets 11 93.549 103.501
Prepaid expenses 14 26.765 19.324
Deferred tax assets 20 39.096 -
Total non-current assets 1.267.589 1.224.605
Total assets 3.441.568 3.315.798

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF FINANCIAL POSITION AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

Notes Reviewed
30 June 2025
Audited
31 December
2024
Liabilities
Current liabilities
Current borrowings 877.988 455.120
-Current borrowings from third parties 877.988 455.120
- Bank loans 6 301.367 455.120
- Issued debt instruments 6 576.621 -
Current portion of long-term borrowings 123.257 129.697
-Current portion of long-term borrowings from third parties 6 123.257 129.697
- Bank loans 82.796 32.634
- Lease liabilities 5.975 55.137
- Issued debt instruments 34.486 41.926
Trade payables
- Trade payables to related parties
22 213.189
15.808
155.134
8.388
- Trade payables to third parties 7 197.381 146.746
Employee benefit obligations 8 52.811 126.153
Other payables 151.706 4.467
- Other payables to related parties 22 150.026 -
- Other payables to third parties 8 1.680 4.467
Derivative instruments 24.1 - 655
Deferred income 14 27.488 71.233
Current provisions 14.742 22.186
- Provisions for employment benefits 13 9.483 16.057
- Other current provisions 12 5.259 6.129
Total current liabilities 1.461.181 964.645
Non-current liabilities
Non-current borrowings
574.669 590.819
- Non-current borrowings from third parties 6 574.669 590.819
-Bank loans 170.000 198.346
-Issued debt instruments 250.000 291.685
- Lease liabilities 154.669 100.788
Employee benefit obligations 8 1.735 2.701
Non-current provisions 37.446 38.970
- Provisions for employment benefits 13 37.446 38.970
Deferred tax liability 20 - 27.955
Total non-current liabilities 613.850 660.445
Equity
Issued Capital
Inflation Adjustment on Capital
15
15
259.875
413.472
259.875
413.472
Other comprehensive income/(expenses) that will not
be reclassified to profit or loss (22.358) (17.482)
- Losses on remeasurement of defined benefit obligations (22.358) (17.482)
Other comprehensive income/(expenses) that will
be reclassified to profit or loss 14.250 14.547
- Gains/(loss) on hedge 14.250 14.547
Restricted reserves appropriated from profits 15 348.373 351.582
Prior years' profits/(losses) 15 517.514 646.961
Net profit/(loss) for the period (164.589) 21.753
Total equity 1.336.537 1.690.708
Total liabilities 3.441.568 3.315.798

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF PROFIT OR LOSS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

Profit or loss Notes Reviewed
1 January -
30-June-25
Reviewed
1 January -
30-June-24
Not
Reviewed
1 April -
30-June-25
Not
Reviewed
1 April
30-June-24
Revenue 16 958.610 1.730.157 664.850 758.830
Cost of sales (-) 16 (545.168) (766.976) (364.566) (353.772)
Gross profit / (loss) 413.442 963.181 300.284 405.058
General administrative expenses (-) (230.159) (261.073) (96.463) (142.109)
Marketing expenses (-) (284.666) (321.653) (121.593) (142.411)
Research and development cost (-) (7.877) (8.522) (2.547) (4.070)
Other income from operating activities 17 11.505 15.675 8.427 624
Other expenses from operating activities (-) 17 (8.153) (17.905) (2.914) 46.612
Operating profit / (loss) (105.908) 369.703 85.194 163.704
Investment activity income 18 65 631 45 20.148
Investment activity expenses (-) 18 (1.471) (63.677) (1.471) (56.873)
Operating profit / (loss) before
financing income / (expenses) (107.314) 306.657 83.768 107.374
Finance income 19 77.029 256.554 28.998 126.499
Finance expenses (-) 19 (296.053) (401.975) (154.026) (179.150)
Monetary gain / (loss) 25 96.419 89.235 42.239 24.633
Profit / (loss) before tax from continuing
operations (229.919) 250.471 979 79.356
Tax expense from continuing operations 65.330 (49.322) 47.218 (6.267)
- Current period tax expense 20 - (60.942) - (7.635)
- Deferred tax income / (expense) 20 65.330 11.620 47.218 1.368
Net profit / (loss) (164.589) 201.149 48.197 73.089
Earnings / (loss) per share (Full TRL) 21 (0,6333) 8,5142 0,1855 3,0937

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF OTHER COMPREHENSIVE INCOME FOR THE SIX-MONTH PERIOD ENDED JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

Reviewed Reviewed
1 January
Not
Reviewed
Not
Reviewed
Notes 1 January -
30-June-25
-
30-June-24
1 April -
30-June-25
1 April -
30-June-24
Net profit / (loss) for the year (164.589) 201.149 48.197 73.089
Other comprehensive expenses that will
not be reclassified to profit or loss (4.876) 9.610 (1.354) (2.545)
- Gains / (losses) on remeasurements of
defined benefit plans
13 (6.501) 12.814 (1.806) (3.392)
Other comprehensive expenses that will
not be reclassified to profit or loss, tax effect 1.625 (3.204) 452 847
- Deferred tax (expense) / income 1.625 (3.204) 452 847
Other comprehensive expenses that will
be reclassified to profit or loss
- Other comprehensive income / (expense)
(297) 216 (1.797) (1.966)
on cash flow hedge (396) 288 (2.396) (2.621)
-Other comprehensive expenses that will
be reclassified to profit or loss, tax effect 99 (72) 599 655
- Deferred tax income /(expense) 99 (72) 600 655
Other comprehensive income / (expense) (5.173) 9.826 (3.151) (4.511)
Total comprehensive income / (expense) (169.762) 210.975 45.046 68.578

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF CHANGES IN EQUITY FOR THE SIX-MONTH PERIOD ENDED JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

Other comprehensive
income / (loss) that will
not be reclassified in
profit or loss
Other comprehensive
be
loss
income / (loss) that will
reclassified in profit or
Accumulated profits
Issued capital Inflation
adjustment
on capital
Defined benefit plans
revaluation and
measurement gains /
(losses)
Currency
translation
differences
Gains /
(losses) on
hedge
Restricted
reserves
Retained
earnings
Net profit /
(loss) for the
period
Total
equity
Balances as of 1 January 2024 23.625 649.725 (23.328) (6.634) 16.462 332.608 144.374 734.399 1.871.231
Liquidation effect
Transfers
Dividends
Total comprehensive income / (loss)
Balances as of 30 June 2024
-
-
-
-
23.625
-
-
-
-
649.725
-
-
-
9.610
(13.718)
6.634
-
-
-
-
-
-
-
216
16.678
-
516
-
-
333.124
-
733.883
(212.833)
-
665.424
-
(734.399)
-
201.149
201.149
6.634
-
(212.833)
210.975
1.876.007
Balances as of 1 January 2025 259.875 413.472 (17.482) - 14.547 351.582 646.961 21.753 1.690.708
Transfers
Dividends
Total comprehensive income / (loss)
-
-
-
-
-
-
-
-
(4.876)
-
-
-
-
-
(297)
(3.209)
-
-
24.962
(154.409)
-
(21.753)
-
(164.589)
-
(154.409)
(169.762)
Balances as of 30 June 2025 259.875 413.472 (22.358) - 14.250 348.373 517.514 (164.589) 1.366.537

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

INTERIM CONDENSED STATEMENT OF CASH FLOWS FOR THE SIX-MONTH PERIOD ENDED JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

Notes Reviewed
January 1-
June 30, 2025
Reviewed
January 1-
June 30, 2024
CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES (772.849) (596.907)
Net profit / (loss) for the period (164.589) 201.149
Adjustments to reconcile net profit / (loss) for the period 186.266 256.390
Adjustments for depreciation and amortization expense 6,10,11 90.207 105.591
Adjustments for impairment loss / (reversal)
- Adjustments for impairment / (reversal) of receivables
7 1.259
1.259
946
946
Adjustments for provisions 13.673 60.878
- Adjustments for provisions / (reversal) for employee benefits 13 13.673 58.649
- Adjustments for provisions / (reversal) for lawsuit 12 - 2.229
Adjustments for interest income / (expenses) 257.642 180.826
- Adjustments for interest income 19 (32.411) (182.235)
- Adjustments for interest expenses 19 290.053 363.482
- Rediscount on interest loss 16 - (421)
Adjustments for fair value gain / (loss) (2.269) (4.201)
Adjustments for tax income / (loss) 20 (65.330) 49.322
Adjustments for gain / (loss) on sale of tangible and intangible assets 1.406 (105)
Monetary gain / loss (110.322) (136.867)
Changes in working capital (875.634) (749.905)
Adjustments for increase / (decrease) in trade receivables (530.968) (826.611)
Adjustments for increase / (decrease) in other receivables (1.765) 8.133
Adjustments for increase / (decrease) in inventory (172.808) (98.771)
Adjustments for increase / (decrease) in prepaid expenses (151.257) (118.645)
Adjustments for increase / (decrease) in trade payables 58.055 (2.870)
Adjustments for increase / (decrease) in employee benefit obligations (74.308) (43.094)
Adjustments for increase / (decrease) in other payables from operations (2.787) 25.066
Increase / (decrease) in deferred income (other than obligations arising from customer
contracts (43.745) (103.462)
Adjustments for other increase / (decrease) in working capital 43.949 410.349
- Increase / (decrease) in other operating assets 72.781 410.481
- Increase / (decrease) in other operating liabilities (28.832) (132)
Cash flows from (used in) operating activities (853.957) (292.366)
Payments related with provisions for employee benefits 13 (21.892) (8.326)
Income taxes (paid) return 103.000 (296.215)
CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES (37.834) (27.040)
Cash inflows arising from sale of tangible and intangible assets 10 65 1.202
Cash outflows arising from purchase of tangible and intangible assets 10 (37.899) (28.242)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES 270.803 (336.573)
Proceeds from borrowings 6 827.025 318.979
Repayments of borrowings 6 (321.173) (372.042)
Repayment of lease liabilities (42.240) (37.404)
Interest paid 6 (225.050) (312.638)
Interest received
Other cash inflows (outflows)
32.241
-
181.279
(114.747)
EFFECT OF MONETARY GAIN/ (LOSS) ON CASH AND CASH EQUIVALENTS (76.681) (237.794)
NET INCREASE / (DECREASE) IN CASH AND CASH EQUIVALENTS (616.561) (1.198.314)
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD 4 768.317 1.317.381
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD 4 151.756 119.067

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 1 – COMPANY'S ORGANIZATON AND NATURE OF OPERATIONS

Adel Kalemcilik Ticaret ve Sanayi A.Ş. ("the Company") 's fields of activity are the production of wooden wall pencils, colored pencils, toy products and other stationery products, sale of hygiene products, the sale and export of the products manufactured in the facilities and importing purchasing and selling of all kinds of raw, semi-finished and finished products.

The company was established on 17 July 1967 and registered with the Istanbul Chamber of Industry (ICI) and the Istanbul Chamber of Commerce (ICOC) on the same date with the registration number 96078.

The registered address of the company's headquarters is as follows:

Fatih Sultan Mehmet Dist. Balkan St. No:58 Buyaka E Block 34771 Tepeüstü - Ümraniye/İstanbul

The Company is registered to the Capital Markets Board ("CMB") and its shares have been traded on Borsa Istanbul ("BIST") since 1996. As of 30 June , the Company has 27.71% of its shares registered in the BIST. The shareholders holding the majority of the Company's shares and their share ratios are as follows:

List of Shareholders

30 June 2025 31 December 2024
(%) TRL (%) TRL
AG
Anadolu
Grubu
Holding
A.Ş.
56,89 147.831 56,89 147.831
Faber-Castell Aktiengesellschaft 15,40 40.017 15,40 40.017
Shares publicly held 27,71 72.027 27,71 72.027
259.875 259.875

The average number of employees of the Company as at 30 June 2025 is 327 (31 December 2024:371).

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS

2.1 Basis of preparation and presentation of financial statements

2.1.1 Statement of compliance with TFRS

The accompanying financial statements are prepared in accordance with the requirements of Capital Markets Board ("CMB") Communiqué Serial II, No: 14.1 "Basis of Financial Reporting in Capital Markets", which was published in the Official Gazette No:28676 on June 13, 2013. The accompanying financial statements are prepared based on the Turkish Accounting Standards and interpretations ("TAS") issued by the Public Oversight Accounting and Auditing Standards Authority ("POA") under Article 5 of the Communiqué. It is also presented in accordance with the 2025 TFRS Taxonomy updated by POA on July 3, 2024.

The Company's companies operating in Türkiye maintain their books of account and prepare their statutory financial statements in Turkish Lira in accordance with the principles and requirements issued by the Capital Markets Board ("CMB"), the Turkish Commercial Code ("TCC") and Tax Legislation and the Uniform Chart of Accounts issued by the Ministry of Finance.

In accordance with TAS 34 "Interim Financial Reporting", entities are free to prepare their interim financial statements as a full set or condensed. In this context, the Company has preferred to prepare condensed interim financial statements. The condensed interim financial statements and notes are presented including the information required by the CMB.

The interim condensed financial statements should be read in conjunction with the audited financial statements and the accompanying notes as of December 31, 2024.

The financial statements of the Company as of June 30, 2025 were approved by the Board of Directors of the Company on August 11, 2025. The General Assembly is authorized to amend the financial statements.

2.1.2 Adjustment of financial statements in hyperinflationary periods

The Company prepared its financial statements as at and for the period ended June 30, 2025 by applying TAS 29 "Financial Reporting in Hyperinflationary Economies" in accordance with the announcement made by POA on 23 November 2023 and the "Implementation Guide on Financial Reporting in High Inflation Economies". The standard requires that financial statements prepared in the currency of a hyperinflationary economy be expressed in terms of the purchasing power of that currency at the balance sheet date and that comparative figures for prior period financial statements be expressed in terms of the measuring unit current at the end of the reporting period. Accordingly, the Company has also presented its financial statements as of 31 December 2025 in terms of the purchasing power of that currency as of 30 June 2025.

In accordance with the CMB's decision dated 28 December 2023 and numbered 81/1820, it has been decided that issuers and capital market institutions subject to financial reporting regulations applying Turkish Accounting/Financial Reporting Standards will apply inflation accounting in accordance with TAS 29 standards, starting from their annual financial reports for the accounting periods ending as of 31 December 2023.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.1 Basis of preparation and presentation of financial statements (Continued)

The restatements in accordance with TAS 29 have been made using the adjustment factor derived from the Consumer Price Index ("CPI") in Türkiye published by the Turkish Statistical Institute ("TSI"). As of June 30, 2025, the indexes and adjustment factors used in the restatement of the financial statements are as follows:

Date Index Adjustment
Coefficent
Three-Year
Compound
Inflation Rate
30 June 2025 3.132,17 1,00000 %220
31 December 2024 2.684,55 1,16674 %291
30
June 2024
2.319,29 1,35049 %324

The main elements of the Company's adjustment for financial reporting purposes in high-inflation economies are as follows:

  • The current period financial statements prepared in TRL are expressed with the purchasing power at the balance sheet date, and the amounts from previous reporting periods are also expressed by adjusting according to the purchasing power at the end of the reporting period.
  • Monetary assets and liabilities are not adjusted as they are currently expressed with current purchasing power at the balance sheet date. In cases where the inflation-adjusted values of nonmonetary items exceed the recoverable amount or net realizable value, the provisions of TAS 36 and TAS 2 were applied, respectively.
  • Non-monetary assets and liabilities and equity items that are not expressed in current purchasing power at the balance sheet date have been corrected using the relevant correction coefficients.
  • All items included in the comprehensive income statement, except those that affect the statement of comprehensive income of non-monetary items in the balance sheet, are indexed with coefficients calculated over the periods when the income and expense accounts are first reflected in the financial statements.
  • The effect of inflation on the Company's net monetary asset position in the current period is recorded in the net monetary gain / loss account in the income statement.

2.1.3 Functional and reporting currency

The Company is based on the Turkish Commercial Code ("TCC"), tax legislation and the Uniform Chart of Accounts issued by the Ministry of Finance of the Republic of Türkiye in keeping its accounting records and preparing its statutory financial statements. Investments valued by the equity method in foreign countries, have prepared their statutory financial statements in accordance with the laws and regulations applicable in the countries in which they operate. Financial statements of company have been prepared in Turkish lira on the basis of historical cost, excluding financial assets and liabilities that are expressed at their fair values. The financial statements have been prepared by reflecting the necessary adjustments and classifications in order to make the correct presentation in accordance with TMS/TFRS to the legal records prepared on the historical cost basis.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.1 Basis of preparation and presentation of financial statements (Continued)

2.1. 4 Comparative information and restatement of prior period financial statements

Comparative figures are reclassified, where necessary, to conform to changes in presentation in the current period financial statements and significant changes are explained. The financial statements of the Company include comparative financial information to enable the determination of the trends in the financial position and performance. The Company has prepared its financial position statement as of 30 June 2025 with the financial position statement prepared as of 31 December 2024; The profit or loss statement for the period 1 January- 30 June 2025, the profit or loss statement for the 1 January- 30 June 2024 accounting period, and the other comprehensive income statement for the 1 January- 30 June 2025 accounting period, the 1 January- 30 June 2024 accounting period, other comprehensive income statement, cash flow statement for the accounting period 1 January-30 June 2025 and statements of changes in shareholders' equity are prepared comparatively with the related financial statements for the accounting period 1 January – 30 June 2024.

The amount of TRL19.606 shown under "Profit on sale of funds" in "Investment activity income" in the income statement dated June 30, 2024 has been classified under "Profit on sale of funds" in "Finance income."

2.2 New and revised Turkish financial reporting standards

Disclosures regarding the impacts of the new IFRS/TFRS on the financial statements:

  • a) Standards, amendments, and interpretations applicable as of 30 June 2025:
  • Amendments to TAS 21 Lack of Exchangeability; effective from annual periods beginning on or after 1 January 2025. An entity is impacted by the amendments when it has a transaction or an operation in a foreign currency that is not exchangeable into another currency at a measurement date for a specified purpose. A currency is exchangeable when there is an ability to obtain the other currency (with a normal administrative delay), and the transaction would take place through a market or exchange mechanism that creates enforceable rights and obligations.
  • b) Standards, amendments, and interpretations that are issued but not effective as of 30 June 2025:
  • Amendment to TFRS 9 and TFRS 7 Classification and Measurement of Financial Instruments; effective from annual reporting periods beginning on or after 1 January 2026 (early adoption is available). These amendments:
    • clarify the requirements for the timing of recognition and derecognition of some financial assets and liabilities, with a new exception for some financial liabilities settled through an electronic cash transfer system;
    • clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion;

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.2 New and revised Turkish financial reporting standards (Continued)

  • b) Standards, amendments, and interpretations that are issued but not effective as of 30 June 2025 (Continued):
    • add new disclosures for certain instruments with contractual terms that can change cash flows (such as some instruments with features linked to the achievement of environment, social and governance (ESG) targets); and
    • make updates to the disclosures for equity instruments designated at Fair Value through Other Comprehensive Income (FVOCI).
  • Annual improvements to IFRS Volume 11; effective from annual periods beginning on or after 1 January 2026 (earlier application permitted). Annual improvements are limited to changes that either clarify the wording in an Accounting Standard or correct relatively minor unintended consequences, oversights or conflicts between the requirements in the Accounting Standards. The 2024 amendments are to the following standards:
    • IFRS 1 First-time Adoption of International Financial Reporting Standards;
    • IFRS 7 Financial Instruments: Disclosures and its accompanying Guidance on implementing IFRS 7;
    • IFRS 9 Financial Instruments;
    • IFRS 10 Consolidated Financial Statements; and
    • IAS 7 Statement of Cash Flows.
  • Amendment to TFRS 9 and TFRS 7 - Contracts Referencing Nature-dependent Electricity; effective from annual periods beginning on or after 1 January 2026 but can be early adopted subject to local endorsement where required. These amendments change the 'own use' and hedge accounting requirements of TFRS 9 and include targeted disclosure requirements to TFRS 7. These amendments apply only to contracts that expose an entity to variability in the underlying amount of electricity because the source of its generation depends on uncontrollable natural conditions (such as the weather). These are described as 'contracts referencing naturedependent electricity'.
  • TFRS 18 Presentation and Disclosure in Financial Statements; effective from annual periods beginning on or after 1 January 2027. This is the new standard on presentation and disclosure in financial statements, with a focus on updates to the statement of profit or loss. The key new concepts introduced in TFRS 18 relate to:
    • the structure of the statement of profit or loss;
    • required disclosures in the financial statements for certain profit or loss performance measures that are reported outside an entity's financial statements (that is, managementdefined performance measures); and
    • enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes in general.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.2 New and revised Turkish financial reporting standards (Continued)

  • b) Standards, amendments, and interpretations that are issued but not effective as of 30 June 2025 (Continued):
  • TFRS 19 Subsidiaries without Public Accountability: Disclosures; effective from annual periods beginning on or after 1 January 2027. This new standard works alongside other TFRS Accounting Standards. An eligible subsidiary applies the requirements in other TFRS Accounting Standards except for the disclosure requirements and instead applies the reduced disclosure requirements in TFRS 19. TFRS 19's reduced disclosure requirements balance the information needs of the users of eligible subsidiaries' financial statements with cost savings for preparers. TFRS 19 is a voluntary standard for eligible subsidiaries. A subsidiary is eligible if:
    • it does not have public accountability; and
    • it has an ultimate or intermediate parent that produces consolidated financial statements available for public use that comply with IFRS Accounting Standards.
  • TFRS 17, Insurance Contracts; effective from annual periods beginning on or after 1 January 2026. This standard replaces TFRS 4, which previously permitted a wide range of accounting practices. TFRS 17 will fundamentally change to the accounting practices of all entities issuing insurance contracts and investment contracts with discretionary participation features.

2.3 Changes and errors in accounting estimates

Accounting estimates are made on the basis of reliable information and reasonable estimation methods. However, estimates are revised if there is a change in the circumstances under which the estimate was made, or if new information becomes available, or if additional developments occur. The effect of a change in an accounting estimate is recognized in the current period in which the change is made, if the change affects only one period, or prospectively in both the current and future periods, if the change affects future periods, in the financial statements in a manner that takes into account in determining the profit or loss for the period.

The nature and amount of any change in an accounting estimate that has an effect on the result of operations in the current period or is expected to have an effect on subsequent periods is disclosed in the notes to the financial statements, except where it is not possible to estimate the effect on future periods. As of June 30, 2025, there have been no changes and errors in accounting estimates.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 2 – BASIS OF PRESENTATION OF FINANCIAL STATEMENTS (Continued)

2.4 Seasonality of activities

The Company starts with a sales campaign for certain products at the beginning of the year and then organizes "dealer fairs" in the first quarter of the year to sell the brands it produces and imports. During these sales campaigns and dealer fairs, checks, DDS, credit cards are taken against the order amounts of the customers and most of the shipment of the orders received is realized in the first half of the year.

2.5 Significant accounting judgments, estimates and assumptions

Fair values of derivatives and other financial instruments

The Company calculates the fair values of financial instruments that do not have an active market by using market data, the use of similar transactions without collusion, reference to the fair values of similar instruments and discounted cash flow analysis.

Expected credit losses

Provision for doubtful receivables is accounted for using expected credit losses defined in TFRS 9 standard. Calculated using expected credit losses and excluding dealers subject to the Direct Debit System, taking into account the company's forecasts for the future, in addition to past experience.

NOTE 3 – SEGMENT REPORTING

Fields of activity of the Company established in Türkiye are, respectively, the production of wooden wall pencils, colored pencils, toy products and other stationery equipment, the sale and export of finished products in the facilities, and importing all kinds of raw materials, semi-finished products and finished products, to buy and sell.

The Company's field of activity, the nature and economic characteristics of the products, the production processes, the classification according to the risks of the customers and the methods used in the distribution of the products are similar. In addition, the organizational structure of the Company has been established in such a way that a single activity is managed instead of the Company being managed in separate divisions containing different activities. For these reasons, the Company's operations are considered as a single operating segment, and the Company's operating results, the determination of the resources to be allocated to these activities, and the examination of the performances of these activities are evaluated within this framework.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 4 – CASH AND CASH EQUIVALENTS

30 June 2025 31 December 2024
Time deposit 150.777 41.096
Demand deposit 397 190
Other cash and equivalents 582 727.031
Cash and cash equivalents in the statement of cash
flows
151.756 768.317
Interest income accruals 170 956
151.926 769.273

The Company has no blocked deposits as of 30 June 2025 (31 December 2024: None).

NOTE 5 – FINANCIAL INVESTMENTS

30 June 2025 31 December 2024
% TRL % TRL
Ülkü
Kırtasiye
Ticaret
ve
Sanayi
A.Ş.
7,67 105 7,67 105
(*)
Other long-term investments
- 1.386 - 1.418
1.491 1.523

(*) It is the amount of venture capital investment fund received by our company on a long-term basis, equal to 2% of the corporate tax incentive amount used, as it is an R&D center.

NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS

30 June 2025 Interest rate % Balance
Short term borrowings
TRL loans 23,47- 48,00 301.367
(*)
Issued debt instruments
TLref + %1 576.621
877.988

(*) The Company will sell to qualified investors without public offering debt instruments worth TRL500,000 with a maturity of 364 days, carrying a variable interest rate of 100 basis points linked to the BIST TLREF index, with two coupon payments and redemption dated 13 March 2026.

As of 30 June 2025, the interest accrual calculated for the Company's short-term loans is classified within the relevant short-term bank loans, and the interest accrual calculated for the issued debt instruments is classified within the issued debt instruments.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS (Continued)

30 June 2025 Interest rate % Balance
Short-term portions of long-term borrowings
Short-term portions of long-term lease
liabilities
5.975
Short-
term portions of long term loans
TLref + %1 82.796
Short-term portions of long-term debt instruments TLref + %1 34.486
123.257

As of 30 June 2025, the interest accrual calculated for the Company's short-term loans is classified within the relevant short-term bank loans, and the interest accrual calculated for the issued debt instruments is classified within the issued debt instruments.

30 June 2025 Interest rate % Balance
Long term borrowings
TRL loans TLref + %1 170.000
Issued debt instruments (*) TLref + %1 250.000
Long-term lease liabilities 154.669

574.669

(*) The Company has debt instruments amounting to TRL250,000, with a maturity of 730 days, carrying a variable interest rate of 100 basis points linked to the BIST TLREF index, with four coupon payments, and redemption dated 24 September 2026. These instruments are offered domestically to qualified investors without a public offering.

31 December 2024 Interest rate % Balance
Long
term borrowings
TRL loans 48,00
-
54,00
455.120
455.120

As of 31 December 2024, the interest accrual calculated for the short-term loans of the Company has been classified under the related short-term bank loans.

31 December 2024 Interest rate % Balance
Short-term portions of
long-term borrowings
Short-term portions of long-term lease
liabilities
55.137
Short-term portions of long-term loans TLref
+
%1
32.634
Short-term portions of long-term
issued debt instruments TLref
+
%1
41.926
129.697

As of December 31, 2024, the accrued interest related to the current portions of long-term borrowings has been classified within the current portions of the respective long-term borrowings.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS (Continued)

31 December 2024 Interest rate % Balance
Long term borrowings
TRL loans TLref
+
%1
198.346
Issued debt instruments TLref
+
%1
291.685
Long-term lease liabilities 100.788

As of 30 June 2025, and 31 December 2024, the maturity details of the Company's long-term loans and financial lease borrowings are given below.

590.819

30 June 2025 Total
liabilities
1-2 years 574.669
574.669
31 December 2024 Total
Liabilities
1-2 years 590.819

The movement of financial borrowings is as follows:

2025 2024
1 January 1.019.711 1.688.330
Cash inflows from borrowings 827.025 318.979
Cash outflows related to debt payments (321.173) (372.042)
Interest expense 266.337 348.513
Interest
paid
(225.050) (312.638)
Monetary (gain)/loss (151.580) (325.268)
30 June 1.415.270 1.345.874

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 6 – BORROWINGS AND RIGHT OF USE ASSETS (Continued)

The movement of lease liabilities is as follows:

2025 2024
1 January 155.925 186.047
Cash inflows from borrowings - 148.840
Cash outflows related to lease payments for the period (42.240) (37.404)
Interest expense 23.717 14.970
Changes in contracts 50.258 -
Monetary (gain)/loss (27.016) (109.073)
30 June 160.644 203.380

The movement of the Company's right of use assets as of June 30, 2025 and June 30, 2024 is presented below.

Right of use assets Vehicles Buildings Total
As of 1 January 2024, 37.550 141.108 178.658
Changes in contracts - 50.258 50.258
Current depreciation expense(*) (14.788) (21.007) (35.795)
As of 30 June 2025 22.762 170.359 193.121

(*) 155 TRL of depreciation expenses is included in the cost of goods sold, 7.921 TRL is included in general administrative expenses and 27.719 TRL is included in marketing, selling and distribution expenses.

Right of use assets Vehicles Buildings Total
As of 1 January 2023, 47.128 179.915 227.043
Additions - 148.840 148.840
Diposals (2.663) (145.263) (147.926)
Current depreciation expense(*) (13.924) (30.506) (44.430)
As of 30 June 2024 30.541 152.986 183.527

(*) TRL 269 of depreciation expenses is included in the cost of goods sold, TRL 4.374 is included in general administrative expenses and TRL 39.787 is included in marketing, selling and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 7 – TRADE RECEIVABLES AND PAYABLES

Trade Receivables 30 June 2025 31 December 2024
Trade receivables from related parties (Note 22) 43.940 49.870
Trade receivables from third parties 638.853 103.213
682.793 153.083
Trade receivables from third parties 30 June 2025 31 December 2024
Cheques and notes receivables
Trade receivables
4.090
643.574
1.836
110.083
Less: Provisions for doubtful trade receivables (-) (8.811) (8.706)

As of 30 June 2025, and 2024, the movement for doubtful trade receivables is as follows:

2025 2024
1 January 8.706 10.745
Provision provided during the period 1.759 946
Reversal of impairment losses (500) -
Inflation correction differences (1.154) (2.150)
30 June 8.811 9.541
Trade payables 30 June 2025 31 December 2024
Trade payables to related parties (Note 22) 15.808 8.388
Trade payables to third parties 197.381 146.746
213.189 155.134
Trade payables to third parties 30 June 2025 31 December 2024
Suppliers 197.291 139.571
Other trade payables 90 7.175
197.381 146.746

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 8 – OTHER RECEIVABLES AND PAYABLES

Other receivables 30 June 2025 31 December 2024
Other receivables from third parties 3.544 1.779
3.544 1.779
Other receivables from third parties 30 June 2025 31 December 2024
Receivables from employees 605 1.161
Deposits and guarantees given 332 409
Other miscellaneous receivables 2.607 209
3.544 1.779
Other payables 30 June 2025 31 December 2024
Other payables to related parties (Note 22) 150.026 -
Other payables to third parties 1.680 4.467
151.706 4.467
Other payables to third parties 30 June 2025 31 December 2024
Taxes, fees and deductions payables
Other
889
791
3.678
789
Employee benefit liabilities 1.680
30 June 2025
4.467
31 December 2024
Due to employees 31.924 72.972
Social security premiums payable 10.855 10.906
Taxes, fees and deductions payables 10.032 42.275
52.811 126.153
Other long-term employee benefit liabilities 30 June 2025 31 December 2024
Due to employees 1.735 2.701

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 9 – INVENTORIES

30 June 2025 31 December 2024
Raw materials 296.723 245.420
Semi-finished goods 132.911 118.856
Finished goods 356.005 311.348
Trade goods 324.726 261.410
Other inventories 12.859 13.382
Impairment of inventories (*) (29.352) (29.352)
1.093.872 921.064

(*) As of 30 June 2025 and 2024, the movement table for the provision for inventory impairment, as a result of the assessment of the recoverability of inventories, is as follows:

2025 2024
1 January 29.352 27.553
Provisions no longer required - -
31 December 29.352 27.553

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS

AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 10 – PROPERTY, PLANT AND EQUIPMENT

Land Machinery
Lands improvements
and buildings
Buildings and
equipment
Vehicles Fixtures Construction
in progress
Special
Costs
Total
As of 1 January 2025,
Cost 50.574 23.960 790.250 1.103.302 17.679 300.314 30.696 5.331 2.322.106
Accumulated depreciation - (22.014) (162.914) (926.431) (17.649) (267.445) - (4.054) (1.400.507)
Net book value 50.574 1.946 627.336 176.871 30 32.869 30.696 1.277 921.599
Opening balance 50.574 1.946 627.336 176.871 30 32.869 30.696 1.277 921.599
Additions - - - 1.492 - 2.017 28.639 - 32.148
Disposals cost - - - (20.444) - (41.889) - - (62.333)
Disposals accumulated depreciation - - - 20.444 - 41.889 - - 62.333
Transfers - - - - - - (2.998) - (2.998)
Depreciation (*) - (163) (8.784) (22.510) (10) (5.514) - (201) (37.182)
Closing balance 50.574 1.783 618.552 155.853 20 29.372 56.337 1.076 913.567
As of 30 June 2025,
Cost 50.574 23.960 790.250 1.084.350 17.679 260.442 56.337 5.331 2.288.923
Accumulated depreciation - (22.177) (171.698) (928.497) (17.659) (231.070) - (4.255) (1.375.356)
Net book value 50.574 1.783 618.552 155.853 20 29.372 56.337 1.076 913.567

(*) 28.928 TRL of depreciation expenses is included in the cost of goods sold, 1.416 TRL is included in general administrative expenses, 1.543 TRL is included in research and development expenses, and 5.295 TRL is included in marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS

AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 11 – PROPERTY, PLANT AND EQUIPMENT (Continued)

Land
improvements
Machinery
and
Construction in Special
Lands and buildings Buildings equipment Vehicles Fixtures progress Costs Total
As of 1 January 2024,
Cost 50.574 23.960 787.891 1.089.763 17.679 295.093 - 6.097 2.271.057
Accumulated
depreciation
- (21.685) (143.906) (885.438) (17.636) (261.288) - (2.496) (1.332.449)
Net book value 50.574 2.275 643.985 204.325 43 33.805 - 3.601 938.608
Opening balance 50.574 2.275 643.985 204.325 43 33.805 - 3.601 938.608
Additions - - - 4.708 - 4.848 18.436 - 27.992
Disposals cost - - - (893) - (4.949) - (30) (5.872)
Disposals accumulated depreciation - - - 534 - 4.241 - - 4.775
Depreciation (*) - (153) (10.241) (20.144) - (6.680) - (1.677) (38.895)
Closing balance 50.574 2.122 633.744 188.530 43 31.265 18.436 1.894 926.608
As of 30 June 2024,
Cost 50.574 23.960 787.891 1.093.578 17.679 294.992 18.436 6.067 2.293.177
Accumulated depreciation - (21.838) (154.147) (905.048) (17.636) (263.727) - (4.173) (1.366.569)
Net book value 50.574 2.122 633.744 188.530 43 31.265 18.436 1.894 926.608

(*) 29.608 TRL of depreciation expenses is included in the cost of goods sold, 2.278 TRL is included in general administrative expenses, 735 TRL is included in research and development expenses, and 6.274 TRL is included in marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 11 – INTANGIBLE ASSETS

Intangible assets include computer software, rights and development costs.

License Other
intangible
Rights Developments agreements assets Total
As of 1 January 2025,
Cost 3.744 102.443 278.313 23.852 408.352
Accumulated amortization (3.494) (36.060) (241.457) (23.840) (304.851)
Net book value 250 66.383 36.856 12 103.501
Opening balance 250 66.383 36.856 12 103.501
Additions - 4.107 - 173 4.280
Transfers - 2.998 - - 2.998
Depreciation (*) - (9.932) (7.240) (58) (17.230)
Closing balance 250 63.556 29.616 127 93.549
As of 30 June 2025,
Cost 3.744 109.548 278.313 24.025 415.630
Accumulated amortization (3.494) (45.992) (248.697) (23.898) (322.081)
Net book value 250 63.556 29.616 127 93.549

(*) For the current period, 10.230 TRL of amortization is included in the cost of goods sold, 1.314 TRL is included in the cost of general administrative expenses, 3.190 TRL is included in the cost of research and development expenses, and 2.496 TRL is included in the cost of marketing, sales and distribution expenses.

Rights Developments License
agreements
Other
intangible
assets
Total
As of 1 January 2024,
Cost 3.744 100.534 267.271 22.083 393.632
Accumulated amortizations (3.292) (15.921) (223.223) (18.123) (260.559)
Net book value 452 84.613 44.048 3.960 133.073
Opening balance 452 84.613 44.048 3.960 133.073
Additions (1) - 275 - 274
Depreciation (*) (105) (10.174) (9.259) (2.728) (22.266)
Closing balance 346 74.439 35.064 1.232 111.081
As of 30 June 2024,
Cost 3.743 100.534 267.546 22.083 393.906
Accumulated amortizations (3.397) (26.095) (232.482) (20.851) (282.825)
Net book value 346 74.439 35.064 1.232 111.081

(*) For the current period, TRL 6.621 of amortization is included in the cost of goods sold, TRL 1.101 is included in the cost of general administrative expenses, TRL 3.821 is included in the cost of research and development expenses, and TRL 10.723 is included in the cost of marketing, sales and distribution expenses.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 12 – PROVISIONS, CONTINGENT ASSETS AND LIABILITIES

30 June 2025 31 December 2024
Provisions for lawsuits 5.259 6.129
5.259 6.129

The Company's 15 employees have filed 15 lawsuits against the Company for the cancellation of the termination of their employment contracts, reemployment and other compensation claims and a litigation provision amounting to TRL 5.259 has been set aside as a result of the evaluations of the lawyers in relation to the related lawsuits.

2025 2024
As of 1 January 6.129 315
Provision allocated during the period - 2.229
Inflation difference (870) (132)
As of 30 June 5.259 2.412

Contingent liabilities and contingent assets

After Adel Kalemcilik Ticaret ve Sanayi A.Ş. could not collect its receivable of 60 TRL arising from its current account relationship with its customer, Istanbul 18th Enforcement Directorate file number 2012/20785E and 2012/18797E and Kartal 1st Enforcement Directorate file number 2012/6142E. Enforcement proceedings were carried out with and the sale of the seized real estate was requested on 7 October 2013. The valuation report has been notified and the real estate sales process continues.

2014/14137E, 2014/15246E, 2014/16896E, filed under Izmir 2, 8, 10 and 14th Enforcement Directorate, as a result Adel Kalemcilik Ticaret ve Sanayi A.Ş.'s inability to collect its receivable of 594 TRL arising from its current account relationship with its customer and 2015/574E, enforcement proceedings were initiated against the debtor company, and a payment order notification was issued against the debtor company, by proceeding with the main proceeding through a lien specific to bills of exchange. Investigations continue for the purpose of collecting the receivable.

There are commercial lawsuits filed against Adel Kalemcilik Ticaret ve Sanayi A.Ş. by the employees of the two subcontractors, whose contracts the Company terminated as of 31 August 2013, due to their failure to fulfill their legal obligations towards their employees, within the framework of the principles of joint and several liability. Provision has been made as of 30 June 2025. The company has objected to the enforcement proceedings in question and the proceedings are continuing.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 12 – PROVISIONS, CONTINGENT ASSETS AND LIABILITIES (Continued)

Following the failure of Adel Kalemcilik Ticaret ve Sanayi A.Ş. to collect its receivables arising from its current account relationship with its customer, a lawsuit was filed with the file number 2016/12354 E (New Basis: 2021/14645 E.) filed within the Istanbul Anatolian 17th Enforcement Directorate. Provision has been made for the amount. Main proceedings have been initiated and the assets recorded on the debtor have been inquired about. There are no assets registered in the name of the debtor, investigations are continuing to collect the receivable.

Following the inability of Adel Kalemcilik Ticaret ve Sanayi A.Ş. to collect due to its current account relationship with its customer, a receivable was recorded in the bankruptcy estate with the file number 2017/32 at Istanbul Anadolu 3rd Bankruptcy Directorate. A provision has been made for the said amount.

Due to the Company's inability to collect a receivable of TRL495 arising from an advance payment relationship with its supplier, a legal follow-up has been initiated under file number 2024/25778 at the Gebze Enforcement Office, and a provision has been recognized for the related amount. The main enforcement proceeding has commenced, and investigations have been conducted to identify assets registered under the debtor's name. No assets have been found registered under the debtor. Efforts to collect the receivable are ongoing.

These proceedings are not expected to have a material impact on the Company's operating results, financial position, or liquidity.

Deposits and guarantees given 30 June 2025 31 December 2024
Letters of
guarantee
71.222 18.865
Letters of credit - 45.038

As of 30 June 2025, and 31 December 2024, the tables regarding the Company's collateral/pledge/mortgage ("CPM") position are as follows:

30 June 2025

Letters of guarantees, pledge and mortgages provided by the Company TRL equivalents TRL
A. Total amount of GPMs given on behalf of the Company's legal personality 71.222 71.222
B. Total amount of GPMs given in favor of subsidiaries included in full consolidation - -
Total amount of GPMs given by the Company for the liabilities of 3rd parties in
C. order to run ordinary course of business - -
D. Total amount of other GPM's - -
i. Total amount of GPMs given in favor of the parent Company - -
ii. Total amount of GPMs given in favor of other group companies not in the
scope of B and C above - -
iii. Total amount of GPMs given in favor of third party companies not in the scope
of C above - -
71.222 71.222

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 12 – PROVISIONS, CONTINGENT ASSETS AND LIABILITIES (Continued)

31 December 2024

Letters of guarantees, pledge and mortgages provided by the Company TRL equivalents TRL
A. Total amount of GPMs given on behalf of the Company's legal personality 18.865 18.865
B. Total amount of GPMs given in favor of subsidiaries included in full consolidation - -
Total amount of GPMs given by the Company for the liabilities of 3rd parties in
C. order to run ordinary course of business - -
D. Total amount of other GPM's - -
i. Total amount of GPMs given in favor of the parent Company - -
ii. Total amount of GPMs given in favor of other group companies not in the
scope of B and C above - -
iii. Total amount of GPMs given in favor of third party companies not in the scope
of C above - -
18.865 18.865

The ratio of other CPMs given by the company to the equity of the Company is 0% as of 30 June 2025 (31 December 2024: 0%).

NOTE 13 – EMPLOYEE BENEFITS

Short term employee benefits 30 June 2025 31 December 2024
Premium accruals - 13.292
Provisions for unused vacations 9.483 2.765
9.483 16.057
Long term employee benefits 30 June 2025 31 December 2024
Provisions for employee termination benefits 37.446 38.970
37.446 38.970

The movement table of unused vacation accruals as of 30 June 2025 and 2024 is as follows:

2025 2024
As of 1 January, 2.765 4.339
Additions 13.855 8.636
Charge for the period (6.313) (3.922)
Inflation difference (824) (861)
As of 30 June, 9.483 8.192

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 13 – EMPLOYEE BENEFITS (Continued)

Provisions for employee termination benefits

In accordance with the provisions of the Labor Law in force, there is an obligation to pay the legal severance pay to employees whose employment contract has ended so that they are entitled to severance pay.

In addition, in accordance with the legislation currently in force, there is an obligation to pay the legal severance pay to those who have the right to leave the job by receiving severance pay. As of 1 July 2025, the severance pay to be paid is subject to a monthly ceiling of 53,919,68 full TRL (1 January 2025: 46,655,43 TRL). Severance pay liability is not legally subject to any funding. Severance pay liability is calculated based on the estimation of the present value of the company's possible future liability arising from the retirement of employees. TAS 19 ("Employee Benefits") requires the company to develop its liabilities within the scope of defined monthly plans using actuarial valuation methods. Accordingly, the actuarial assumptions used in calculating total liabilities are stated below:

The main assumption is that the maximum liability amount for each year of service will increase in line with inflation. Therefore, the discount rate applied represents the expected real rate after adjusting for the effects of future inflation. Therefore, the provisions in the accompanying financial statements as of 30 June 2025 and 31 December 2024 are calculated by estimating the present value of the future probable obligation arising from the retirement of the employees.

2025 2024
As of 1 January, 38.970 48.666
Service cost 13.110 17.181
Severance pay paid (15.579) (4.404)
Actuarial loss /(gain) 6.501 (12.814)
Inflation difference (5.556) (9.553)
As of 30 June, 37.446 39.076
30 June 2025 31 December 2024
Discount
rate (%)
2,58 2,58
Turnover rate used in retirement
probability calculation (%) 92,64 92,82

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 14 – OTHER ASSETS AND LIABILITIES

Short-term prepaid expenses 30 June 2025 31 December 2024
Advances given 139.345 15.857
Prepaid
expenses for the next months
25.616 5.288
164.961 21.145
Current tax assets 30 June 2025 31 December 2024
Prepaid taxes and funds 4.694 141.995
4.694 141.995
Other current assets 30 June 2025 31 December 2024
Deferred VAT 72.134 82.778
Other miscellaneous current assets 55 76
72.189 82.854
Long-term prepaid expenses 30 June 2025 31 December 2024
Prepaid expenses for the next years 26.765 19.324
26.765 19.324
Deferred income 30 June 2025 31 December 2024
Advances received 27.488 71.233
27.488 71.233

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 15 – CAPITAL, RESERVES AND OTHER EQUITY ITEMS

Equity

The shareholders of the Company and their shares in the capital are given below.

30 June 2025 31 December 2024
% Share Amount % Share Amount
AG
Anadolu
Grubu
Holding
A.Ş.
56,89 147.831 56,89 147.831
Faber
-
Castell Aktiengesellschaft
15,40 40.017 15,40 40.017
Shares publicly held 27,71 72.027 27,71 72.027
Paid in capital 100,00 259.875 100,00 259.875
Inflation adjustment on capital 413.472 413.472
Total capital 673.347 673.347

Inflation adjustments to share capital represent the effect of restating cash additions to paid-in capital with year-end purchasing power.

Number of shares and share groups and privileges:

40.017.351 shares of the Company, amounting to TRL 40.017 are registered in the name of the holder and 219.857.649 shares, amounting to TRL 219.858 are bearer share certificates in accordance with the Foreign Capital Legislation. There are no privileges granted to shareholders in the election of the Board of Directors.

Restricted reserves

The legal reserves consist of first and second legal reserves in accordance with the TCC. The first legal reserve is appropriated out of the statutory profits at the rate of 5%, until the total reserve reaches a maximum of 20% of the Company's restated share capital. The second legal reserve is appropriated at the rate of 10% of all distributions in excess of 5% of the Company's restated share capital. Under TCC, the legal reserves are only available for netting off losses unless they exceed 50% of the historical paidin share capital otherwise they are not allowed to be used for other purposes. As a result of the sale of the immovable and participation shares evaluated within the scope of Article 5/e of the Corporate Tax Law No. 5520, 75% of the sales profit has been classified as "Profit from the sale of real estate and participation shares".

30 June 2025 31 December 2024
Legal reserves 344.830 344.830
Real estate and subsidiary shares sales profit 1.703 4.912
R&D investment fund 1.840 1.840
348.373 351.582

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 15 – CAPITAL, RESERVES AND OTHER EQUITY ITEMS (Continued)

Retained Earnings

Retained earnings consist of extraordinary reserves and other retained earnings. Publicly listed companies distribute dividends in accordance with the requirements of CMB as explained below:

30 June 2025 31 December 2024
Other retained earnings /(loss) 300.262 393.483
Extraordinary reserves 217.252 253.478
517.514 646.961

As of June 30, 2025 and 2024, the fund items included within equity in the financial statements prepared in accordance with the Tax Procedure Law are as follows:

30 June 2025
Statutory
Amounts
Indexed per
Statutory
Amounts Indexed
Amounts Presented
Retained Earning PPI per CPI in Prior Years' Profit
Inflation adjustments on capital 530.278 413.472 116.806
Restricted reserves 390.379 348.373 42.006

Dividend distribution

In accordance with the CMB decision numbered 7/242 dated 25 February 2005; If the profit distribution amount calculated in accordance with the CMB's regulations regarding the minimum profit distribution obligation, based on the net distributable profit found in accordance with the CMB regulations, can be fully covered from the distributable profit in the legal records, this entire amount will be distributed, and if not, the entire net distributable profit in the legal records will be distributed. If there is a period loss in the financial statements prepared in accordance with CMB regulations or in any of the legal records, no profit distribution will be made. With the decision of the CMB dated 27 January 2010, it was decided not to impose any minimum profit distribution obligation on dividend distribution for publicly held joint stock companies whose shares are traded on the stock exchange.

Capital increase, free of charge, capital inflation adjustment differences and registered values of extraordinary reserves; It can be used for cash profit distribution or loss offset. However, equity inflation adjustment differences are subject to corporate tax if used in cash profit distribution.

The company management took the profit distribution decision at the General Assembly meeting. In case of distribution of these profits, the entire profit distribution amount will be covered from the distributable profit in the legal records.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

1 January -
30 June 2025
1 January -
30 June
2024
1 April -
30 June 2025
1 April -
30 June
2024
Domestic sales 1.374.392 2.498.343 957.096 1.129.535
Foreign sales 59.901 76.992 32.021 22.476
Sales discounts (-) (475.683) (845.178) (324.267) (393.181)
Net sales 958.610 1.730.157 664.850 758.830
Cost of sales (-) (545.168) (766.976) (364.566) (353.772)
Gross profit 413.442 963.181 300.284 405.058

NOTE 16 – REVENUE AND COST OF SALES

The breakdown of the cost of sales by periods is as follows:

1 January -
30 June 2025
1 January -
30 June 2024
1 April -
30 June 2025
1 April -
30 June 2024
Direct material cost 144.149 227.517 73.448 121.449
Direct labor costs 140.847 147.794 68.630 72.767
General production expenses 55.520 66.565 23.326 30.548
Depreciation and
amortization expenses 39.315 36.496 20.039 18.291
Change in
semi-finished goods
(14.055) (31.722) (12.848) 7.525
Change in finished goods (44.655) (684) 37.033 (110.333)
Cost of products sold 321.121 445.966 209.628 140.247
Cost of goods sold 224.047 321.010 154.938 213.525
Cost of sales 545.168 766.976 364.566 353.772

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 17 – OTHER INCOME AND EXPENSES FROM xOPERATING ACTIVITIES

1 January-
-
30 June 2025
1 January
-
30 June 2024
1 April
-
30 June 2025
1 April
-
30 June 2024
Other operating income
Foreign
exchange income
9.643 9.913 6.761 3.503
Cancellation of provision for
doubtful
receivables (Note 7)
500 - 496 -
Other 1.362 5.762 1.170 (2.879)
11.505 15.675 8.427 624
1 January -
30 June 2025
1 January -
30 June 2024
1 April -
30 June 2025
1 April -
30 June 2024
Other operating expenses
Foreign exchange expenses
Provision for doubtful
5.063 6.065 1.035 131
trade receivables (Note 7) 1.759 946 1.234 946
Donation expenses 62 2.500 - 2.500
Lawsuit
provision expenses (Note 12)
- 2.229 - 2.229
Other 1.269 6.165 645 (52.418)
8.153 17.905 2.914 (46.612)

NOTE 18 – INCOME AND EXPENSES FROM INVESTMENT ACTIVITIES

1 January -
30 June 2025
1 January
-
30 June 2024
1 April-
30
June 2025
1 April
-
30 June 2024
Income from investment activities
Proceeds from sale of property, plant
and equipment 65 631 45 543
65 631 45 543

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 18 – INCOME AND EXPENSES FROM INVESTMENT ACTIVITIES (Continued)

1 January - 1 January - 1 April - 1 April -
30 June 2025 30 June 2024 30 June 2025 30 June 2024
Expenses from investment activities
Losses from sale of property, plant and
equipment 1.471 524 1.471 349
Expense arising from cancellation
of the rental agreement - 56.524 - 56.524
Transfer of currency translation
differences recognized in other
comprehensive income in the
prior period to income statement - 6.629 - -
1.471 63.677 1.471 56.873

NOTE 19 – FINANCE INCOME AND EXPENSES

1 January -
30 June 2025
1 January
-
30 June 2024
1 April
-
30 June 2025
1 April -
30 June 2024
Finance income
Profit on
sale of
funds
35.805 19.606 904 19.606
Interest income 32.411 164.157 20.831 60.083
Foreign exchange income 8.813 54.714 7.263 39.472
Currency protected deposit
income - 17.895 - 7.453
Interest income from
sublease receivables - 182 - (115)
77.029 256.554 28.998 126.499
1 January -
30 June 2025
1 January -
30 June
2024
1 April -
30 June 2025
1 April -
30 June
2024
Finance expenses
Interest expenses 290.053 363.482 149.623 140.735
Foreign exchange expenses 6.000 38.493 4.403 38.415
296.053 401.975 154.026 179.150

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 20- DEFERRED TAX ASSETS AND LIABILITIES

The company is subject to taxation in accordance with the tax laws of the countries in which it operates and other legislation.

In Türkiye, the corporate tax rate is 25%. Corporate tax is declared until the twenty-fifth day of the fourth month following the end of the accounting period to which it relates and paid in one lump sum until the end of the relevant month. In accordance with the tax legislation, provisional tax is calculated and paid at the corporate tax rate on quarterly earnings, and the amounts paid in this way are deducted from the tax calculated over the annual income.

Under Turkish tax legislation, tax losses can be carried forward for a maximum of five years following the year in which they were incurred. In addition, tax returns and related accounting records can be examined by the tax administration within five years.

1 January -
30 June 2025
1 January -
30 June 2024
1 April -
30 June 2025
1 April -
30 June 2024
Current period provision for
corporate tax (-)
- (60.942) - (7.635)
Deferred tax
income/(expense)
65.330 11.620 47.218 1.368
Total deferred tax income,
expense (net) 65.330 (49.322) 47.218 (6.267)

The reconciliation of the period's tax expense with the profit for the period is as follows:

Profit for the period tax (liability)/receivable, net 4.694 141.995
Less: Prepaid corporate tax 4.694 141.995
Current period provision for corporate tax - -

30 June 2025 31 December 2024

Tax Advantages Obtained Under the Investment Incentive System:

The Company's earnings from investments subject to incentive certificates are subject to corporate tax at reduced rates from the accounting period in which the investment starts to be operated partially or fully until the investment contribution amount is reached.

Within the scope of the Company's incentive certificates, there is no discounted corporate tax advantage used in return for the current period's legal tax. (30 June 2024: 0 TRL)

The company capitalizes the R&D expenditures made within the scope of the law no. 5746 in its statutory books. In accordance with the provisions of the same law, the Company calculates R&D expenditures within the framework of the relevant legislation and utilizes R&D deductions for the portion of the R&D expenditures allowed by law. As of 30 June 2025, the Company has used R&D deduction exemption amounting to TRL 11.770 (30 June 2024: TRL 3.238) against statutory tax.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 20- DEFERRED TAX ASSETS AND LIABILITIES (Continued)

Deferred tax assets are recognized when it is probable that taxable income will be available in future years. Deferred tax assets are calculated based on tax benefits earned from deductible temporary differences, financial losses, and investment deductions with unlimited life that allow for reduced corporate tax payments. In this context, the Company bases the recognition of deferred tax assets arising from investment incentives in its financial statements on long-term plans and evaluates the recoverability of deferred tax assets related to such investment deductions at each balance sheet date based on business models that include taxable profit forecasts. It is anticipated that the deferred tax assets will be recovered within five years from the balance sheet date.

In the sensitivity analysis conducted as of June 30, 2025, when the inputs in the macroeconomic and sectoral assumptions underlying the business plans were increased/decreased by 10%, there was no change in the five-year recovery periods projected for deferred tax assets related to investment incentives.

Total temporary
differences Deferred tax
30 June 31 December 30 June 31 December
2025 2024 2025 2024
Tangible and intangible assets 15.820 12.099 3.955 3.025
Provisions for employee termination benefits 37.703 36.240 9.426 9.060
Provisions for turnover and dealer premium 181.291 - 45.323 -
Financial loss carried forward 22.344 - 5.586 -
Research and development discount 47.080 - 11.770 -
Adjustments related to derivative instruments 2.887 (4.904) 722 (1.226)
Provision for doubtful receivables 5.733 5.626 1.433 1.407
Inventory, provision for impairment on
inventory (150.974) (160.725) (37.744) (40.181)
Lawsuit provision 5.259 6.129 1.314 1.533
Provision for bulk consumption sales returns 4.536 - 1.134 -
Incentive premium accruals - 13.347 - 3.337
Right of use assets transactions (32.477) (22.734) (8.119) (5.684)
Other adjustments 17.190 3.098 4.296 774
Deferred tax asset/(liability) 156.392 (111.824) 39.096 (27.955)
2025 2024
As of 1 January (27.955) 40.598
Deferred tax income 65.330 11.620
Effect of remeasurement of employee termination
benefit recognized through other comprehensive income
1.622 (3.204)
Effect of remeasurement of derivative financial
instruments recognized through other comprehensive income 99 (72)
30 June 39.096 48.942

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 21 – EARNINGS PER SHARE

Earnings per share is calculated by dividing the profit for the period by the weighted average number of shares of the Company during the period. The Company's earnings per share calculation is as follows.

1 January
-
30 June 2025
1 January
-
30 June 2024
Profit /(loss) for the period (164.589) 201.149
Average
number of shares
(TRL
1 nominal value
weighted average number of shares) 259.875.000 23.625.000
Earnings per share /(loss) (TRL Full) (0,6333) 8,5142

NOTE 22 – RELATED PARTY BALANCES AND TRANSACTIONS

a) Related Party Balances

Receivables from related parties
30 June 2025 31 December 2024
(2)
Migros
Ticaret
A.Ş.
39.496 35.004
A.W. Faber-Castell Vertrieb GmbH(2) 847 3.694
(2)
AEP
Anadolu
Etap
Penkon
Gıda
ve
İçecek
1.502 -
A.W.Faber Castell Peruana SA(2) 800 2.228
(2)
Anadolu
Sağlık
Merkezi
Hastanesi
A.Ş.
- 7.875
Other 1.295 1.069

43.940 49.870 Payables to related parties 30 June 2025 31 December 2024 AEH Sigorta Acentalığı A.Ş. (2) 4.527 20 AG Anadolu Grubu Holding A.Ş. (1) 10.273 7.804 Other 1.008 564 15.808 8.388

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 22 – RELATED PARTY BALANCES AND TRANSACTIONS (Continued)

Other payables
to
related parties
30 June 2025 31 December 2024
Dividend payables to shareholders 150.026 -
150.026 -
Prepaid expenses to related
parties
30 June 2025 31 December 2024
(2)
A.W. Faber-Castell Vertrieb GmbH
A.W. Faber-Castell (Guangzhou)(2)
A.W. Faber-Castell (M)(2)
64.514
29.582
3.090
-
-
-
97.186 -

1) Shareholders

2) Other companies managed by the shareholders

b) Related party transactions

1 January
-
30 June 2025
1 January
-
30 June
2024
1 April
-
30 June 2025
1 April
-
30 June
2024
Purchases of goods
A.W. Faber-Castell Vertrieb
GmbH(2) 54.205 65.454 52.800 61.137
A.W. Faber-Castell (Guangzhou)
Stationery Co. Ltd(2) 33.371 76.712 33.371 76.712
A.W. Faber Castell (M) Sdn.Bhd(2) 63.697 71.647 51.755 71.647
(2)
P.T.A.W.Faber Castell Ind.
2.569 22.432 - 15.260
Other 2.243 2.841 2.243 2.841
156.085 239.086 140.169 227.597
1 January
-
1 January
-
1 April
-
1 April
-
30 June 2025 30 June
2024
30 June 2025 30 June
2024
Sales of goods
(2)
Migros
Ticaret
A.Ş.
36.811 30.354 11.528 30.266
A.W. Faber-Castell Vertrieb
GmbH(2) 8.132 8.980 8.132 6.231
Other 1.321 1.448 946 401
46.264 40.782 20.606 36.898
1 January
-
1 January
-
1 April
-
1 April
-
30 June 2025 30 June
2024
30 June 2025 30 June
2024
Services received
(1)
AG
Anadolu
Grubu
Holding
A.Ş.
38.359 33.329 18.994 16.102
(2)
Anadolu Efes Spor Kulübü
- 7.246 - 7.246
Moneypay Ödeme ve Elektronik
(2)
Para
Hizmetleri
A.Ş.
4.286 - 4.286 -
Other 482 9 380 (9)
43.127 40.584 23.660 23.339

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 22 – RELATED PARTY BALANCES AND TRANSACTIONS (Continued)

1 January
-
30 June 2025
1
January
-
30 June
2024
1 April
-
30 June 2025
1 April
-
30 June
2024
Services given
A.W. Faber-Castell Vetrieb
Gmbh.(2) 5.424 - 5.424 -
(2)
AEP
Anadolu
Etap
Penkon
A.Ş.
8.435 8.363 3.275 3.859
Anadolu Kaskasya
Enerji
(2)
Yatırımları
A.Ş.
2.266 2.101 1.153 976
(2)
Coca
Cola
Satış
ve
Dağ
198 546 198 546
Other 3.984 639 3.920 261
20.307 11.649 13.970 5.642

1) Shareholders

2) Other companies managed by the shareholders

c) Benefits provided to key management

The Company has determined the key management personnel as members of the board of directors, President of Agriculture Energy and Industry Group, general manager and managers reporting directly to the general manager. Benefits provided to key management personnel are as follows:

2025 2024
Short term employee benefits 65.815 57.927
Other long-term benefits 7.172 3.800
Post-employment benefits 5.684 -
Benefits provided due to retirement benefits 1.712 -
80.383 61.727

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS

(a) Capital risk management

The Company manages its capital to ensure that it will maintain its status as a going concern while maximizing the return to stakeholders through the optimization of the debt and equity balance.

The capital structure of the Company consists of debt, which includes the borrowings, cash and cash equivalents and equity attributable to equity holders of the parent, comprising issued capital, reserves and retained earnings. The management of the Company considers the cost of capital and the risks associated with each class of capital. The management of the Company aims to balance its overall capital structure through the payment of dividends, new share issues and the issue of new debt or the redemption of existing debt.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

The Company controls its capital using the net debt / total equity ratio. This ratio is the calculated as net debt divided by total equity. Net debt is calculated as total liability (comprises of financial liabilities, leasing and trade payables as presented in the statement of financial position) less cash and cash equivalents. Total equity is calculated by adding shareholders equity and net debt, as shown in the balance sheet.

The Company's overall strategy based on equity does not differ from the previous period.

The Company does not have speculative financial instruments (including derivative financial instruments) and does not have any activity related to the purchase and sale of such instruments.

As of June 30, 2025 and December 31, 2024, net debt / (equity + net debt) ratio is as follows;

30 June 2025 31 December 2024
Total borrowings 1.415.270 1.175.635
Less: Cash and cash equivalents (151.926) (769.273)
Net debt 1.263.344 406.362
Total
equity
1.366.537 1.690.708
Total equity + net debt 2.629.881 2.097.070
Net debt / (total equity+net debt) ratio %48 %19

(b) Credit risk

The Company's activities expose it to foreign exchange and other risks. The Company is also exposed to the risk that counterparties may not fulfill the requirements of the agreement due to holding financial instruments.

Market risks encountered at the Company level are measured on the basis of sensitivity analysis. In the current year, there has been no change compared to the previous year in the Company's exposure to market risks or in the way the Company handles or measures these risks.

(c) Currency risk and management

Transactions in foreign currency cause the exchange rate risk to occur.

The Company is exposed to exchange rate risk due to changes in the exchange rates used in the conversion of foreign currency assets and liabilities into Turkish lira. Currency risk arises due to future commercial transactions and the difference between recorded assets and liabilities.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

The TRL equivalents of foreign currency assets and liabilities held by the Company are as follows:

30 June 2025 31 December 2024
Assets 151.267 77.025
Liabilities (29.046) (20.958)
Net balance sheet foreign currency position 122.221 56.067

The Company is exposed to currency risk mainly in US Dollar and Euro.

Appreciation of
foreign
Depreciation
Foreign
Profit/Loss 30 June 2024 currency currency
If the US Dollar changes 20% +/- against TRL:
1- USD net asset/liability 19.075 (19.075)
2- Part hedged against USD risk (-) (*) - -
3- USD net effect (1+2) 19.075 (19.075)
In case the Euro changes 20% +/- against TRL:
4- Euro net asset/liability 5.369 (5.369)
5- Hedged portion from Euro risk (-) - -
6- Euro net effect (4+5) 5.369 (5.369)
On average 20% +/- change in other exchange rates against TRL:
7- Other foreign currency net asset/liability - -
8- Hedged portion from other exchange rate risk (-) - -
9- Net effect on other FX assets (7+8) - -
24.444 (24.444)

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

Appreciation of
foreign
Depreciation
Foreign
Profit/(Loss) 31 December 2024 currency currency
If the US Dollar changes 20% +/- against TRL:
1- USD net asset/liability 10.701 (10.701)
2- Part hedged against USD risk (-) (*) - -
3- USD net effect (1+2) 10.701 (10.701)
In case the Euro changes 20% +/- against TRL:
4- Euro net asset/liability 512 (512)
5- Hedged portion from Euro risk (-) - -
6- Euro net effect (4+5) 512 (512)
On average 20% +/- change in other exchange rates against TRL:
7- Other foreign currency net asset/liability - -
8- Hedged portion from other exchange rate risk (-) - -
9- Net effect on other FX assets (7+8) - -
11.213 (11.213)

(*) The effect of derivative instruments for hedging purposes is not taken into account.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

(c) Currency risk and management (Continued)

It summarizes the Company's foreign currency position risk. The recorded amounts of foreign currency assets and liabilities held by the Company are as follows. by foreign currency type:

30 June 2025 31 December 2024
TRL
equivalent
USD Avro Other TRL equivalent USD Avro Other
1. Trade receivables 53.911 1.288 58 - 17.557 285 136 -
2a. Monetary financial assets 22 1 - - 41.096 1.000 - -
2b. Non-monetary financial assets - - - - - - - -
3. Other 97.334 1.704 636 - 18.372 432 15 -
4. Total current assets (1+2+3) 151.267 2.993 694 - 77.025 1.717 151 -
5. Trade receivables - - - - - - - -
6a. Monetary financial assets - - - - - - - -
6b. Non-monetary financial assets - - - - - - - -
7. Other - - - - - - - -
8. Total non-current assets (5+6+7) - - - - - - - -
9. Total assets (4+8) 151.267 2.993 694 - 77.025 1.717 151 -
10. Trade payables 29.046 592 118 - 16.946 319 90 -
11. Financial liabilities - - - - - - - -
12a. Other monetary liabilities - - - - 4.012 96 1 -
12b. Other non-monetary liabilities - - - - - - - -
13. Total current liabilities (10+11+12) 29.046 592 118 - 20.958 415 91 -
14. Trade payables - - - - - - - -
15. Financial liabilities - - - - - - - -
16a. Other monetary liabilities - - - - - - - -
16b. Other non-monetary liabilities - - - - - - - -
17. Total non-current liabilities (14+15+16) - - - - - - - -
18. Total liabilities (13+17) 29.046 592 118 - 20.958 415 91 -
19. Net asset/ (liability) position of off-balance sheet derivative instruments (19a-19b) - - - - 164.385 4.000 - -
19a. Total asset amount hedged - - - - 164.385 4.000 - -
19b. Total liabilities amount hedged - - - - - - - -
20. Net foreign currency asset / (liability) position (9-18+19) 122.221 2.401 576 - 220.452 5.302 60 -
21. Monetary items net foreign currency asset / (liability) position (1+2a+3+5+6a-10-11-12a
14-15-16a) 122.221 2.401 576 - 56.067 1.302 60 -
22. Exports 59.901 1.089 346 - 146.996 2.191 696 6.680
23. Imports 318.079 6.235 1.622 4.764 535.048 10.419 3.349 95
%20 increase - 19.075 5.369 - 9.172 439 -

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS AS AT JUNE 30, 2025

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 23 – NATURE AND LEVEL OF RISKS ARISING FROM FINANCIAL INSTRUMENTS (Continued)

(d) Interest rate risk and management

As of 30 June 2025, the Company does not have any floating rate borrowings. (31 December 2024: None).

(e) Credit risk management

Holding financial instruments also carries the risk that the other party will not be able to fulfill the requirements of the agreement. The Company's collection risk mainly arises from its trade receivables. Trade receivables are evaluated in accordance with the Company's policies and procedures and are recognized net of provision for doubtful receivables.

The majority of the Company's sales are for the domestic market and it is mainly carried out through dealers and wholesalers. About 52% of the sales are due to the sales of the manufactured products. The commercial goods sold by the Company are of foreign origin. Therefore the company's merchandise costs are sensitive to the exchange rate. The cost of raw materials depends on the general price trend in the country. Approximately 94% of the Company's net sales are domestically oriented and the fluctuations in exchange rates are taken into account when determining price levels.

The Company collects its receivables mainly through checks received from its dealers and also uses a direct debit system (DDS) and other collection instruments. The Company mainly uses the direct debit system (DBS) as a collection tool. Since the issuers of the checks received in general are the customers of the dealers, risk distribution is provided. Since the Company operates in this system, there is no significant risk arising from its receivables.

(f) Liquidity risk and management

The Company tries to manage its liquidity risk by regularly monitoring the cash flows and ensuring the continuation of sufficient funds and borrowing reserves by matching the maturities of financial assets and liabilities.

Liquidity risk tables

Prudent liquidity risk management refers to holding sufficient cash, availability of sufficient credit transactions and fund resources, and the power to close market positions.

The funding risk of current and prospective debt requirements is managed by maintaining the availability of sufficient number of high-quality lenders.

The maturity distribution of the Company's derivative and non-derivative financial liabilities in Turkish Lira (TRL) is presented below.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 JUNE 2024

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 24 – FINANCIAL INSTRUMENTS

25.1 Fair value

The Company considers that the carrying values of financial instruments reflect their fair values.

Fair Value Measurements

Level 1: Market price valuation techniques for the determined financial instruments traded in markets (unadjusted)

Level 2: Other valuation techniques including direct or indirect observable inputs

Level 3: Valuation techniques not containing observable market inputs

30 June 2025 Level 1 Level 2 Level 3
Derivative financial liabilities - - - -
31 December 2024 Level 1 Level 2 Level 3
Derivative financial liabilities 655 - 655 -

25.2 Derivative financial instruments and hedge accounting

The Company has started to apply cash flow hedge accounting as of October 1, 2018.

As of June 30, 2025, the Company has a forward transaction. (31 December 2024: Nominal value of TRL 164.385 amounting to USD 4.000.000).

As of 30 June 2025, the Company has allocated USD 555 equivalent of TRL 22 from its bank deposits for the payments related to raw material and trade goods purchases to be made in the future periods in order to hedge against fluctuations in foreign exchange rates and the related amount has been subject to hedge accounting. (31 December 2024: USD 1.000.000 equivalent of TRL 48.644)

At the inception of a hedging transaction, the Company documents the relationship between the hedging instrument and the hedged item, as well as its risk management objectives and strategy for undertaking various hedging transactions. The Company recognizes the hedging instruments used in hedging transactions both at the inception of the hedging transaction and at regular intervals in the hedged items. whether they are highly effective in offsetting changes in their values.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 JUNE 2024

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 24 – FINANCIAL INSTRUMENTS (Continued)

25.2 Derivative financial instruments and hedging transactions (Continued)

The Company is a party to various forward foreign exchange contracts and options depending on the management of exchange rate fluctuations. The derivative instruments purchased are mainly denominated in foreign currencies in the markets in which the Company operates for inventory purchases, purchases of machinery and equipment denominated in foreign currencies and other service contracts denominated in foreign currencies.

2025
Fair Value
2024
Fair Value
Contract
Amount
Assets Liabilities Contract
Amount
Assets Liabilities
For hedging purposes:
Forward transactions - - - 164.385 - 655
- - - 164.385 - 655
Short term - - - 164.385 - 655
- - - 164.385 - 655

Objectives in financial risk management:

The Company's finance department is responsible for ensuring regular access to financial markets and monitoring and managing the financial risks incurred in connection with the Company's activities. These risks are; It includes market risk (including currency risk, fair interest rate risk and price risk), credit risk, liquidity risk and cash flow interest rate risk.

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 JUNE 2024

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 24 – FINANCIAL INSTRUMENTS (Continued)

25.2 Derivative financial instruments and hedging transactions (Continued)

The Company does not have speculative financial instruments (including derivative financial instruments) and does not have any activity related to the purchase and sale of such instruments.

Fair value
differences
reflected in Financial
other Financial assets liabilities shown
comprehensive shown at at amortized
30 June 2025 Note income amortized cost value Book value Fair value
Financial assets
Cash and cash equivalents 4 - 151.926 - 151.926 151.926
Trade receivables from
third parties 7 - 638.853 - 638.853 638.853
Receivables from related
parties 22 - 43.940 - 43.940 43.940
Derivative instruments
Other financial assets 5 - 1.491 - 1.491 1.491
Financial liabilities
Financial borrowings 6 - - 1.415.270 1.415.270 1.415.270
Lease liabilities 6 - - 160.644 160.644 160.644
Trade payables due to
third parties 7 - - 197.381 197.381 197.381
Payables due to related
parties 22 - - 15.808 15.808 15.808
Derivative instruments
Other financial liabilities 8 - - 151.706 151.706 151.706
Fair value
differences
reflected in
other
comprehensive
Financial assets
shown at
Financial
liabilities shown
at amortized
31 December 2024 Note income amortized cost value Book value Fair value
Financial assets
Cash and cash equivalents 4 - 769.273 - 769.273 769.273
Trade receivables from
third parties 7 - 103.213 - 103.213 103.213
Receivables from related
parties 22 - 49.870 - 49.870 49.870
Other financial assets 5 - 1.523 - 1.523 1.523
Financial liabilities
Financial borrowings 6 - - 1.019.711 1.019.711 1.019.711
Lease liabilities 6 - - 155.925 155.925 155.925
Trade payables due to
third parties 7 - - 146.746 146.746 146.746
Payables due to related
parties 22 - - 8.388 8.388 8.388
Derivative instruments 24.1 - - 655 655 655
Other financial liabilities 8 - - 4.467 4.467 4.467

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 JUNE 2024

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 25 – DISCLOSURES ON NET MONETARY POSITION GAINS / (LOSSES)

Non-Monetary Items 30 June 2025 31 December 2024
Financial Position Statement Items
Inventory
142.806 209.440
Prepaid expenses 4.449 5.391
Financial investments 15 21
Property, plant and equipment 131.269 185.067
Intangible assets 14.158 24.577
Right of use assets 32.205 36.300
Deferred
income
(2.095) (34.855)
Adjustment to share capital (96.228) (133.523)
Other comprehensive expenses that will not
be reclassified to profit or loss (5.612) (6.468)
- Losses on remeasurement of defined benefit
obligations (5.612) (6.468)
Other comprehensive income (expenses) that will
be reclassified to profit to loss (2.079) (1.944)
-
Currency translation differences
- 1.314
-
Gains (loss) on hedge
(2.079) (3.258)
Restricted reserves (47.494) (65.963)
Retained earnings (93.933) (164.000)
Profit or Loss Statement Items
Revenue (25.834) (96.851)
Cost of sales (-) 14.419 43.107
Research and development expenses (-) (467) 549
General administrative expenses (-) 8.024 17.245
Marketing expenses (-) 9.671 38.077
Other income from operating activities (349) (903)
Other expenses from operating activities (-) 355 590
Income from investment activities (-) (3.059) (147)
Finance income (1.334) (17.346)
Finance expenses (-) 13.157 27.381
Current period tax expense - 5.618
Deferred tax income (3.995) 8.050
Other Comprehensive Income Statement Items
Other comprehensive income (expenses) that will not be
reclassified 8.370 9.822
NET MONETARY POSITION GAINS/(LOSSES) 96.419 89.235

ADEL KALEMCİLİK TİCARET VE SANAYİ A.Ş.

NOTES TO THE FINANCIAL STATEMENTS FOR THE INTERIM PERIOD 30 JUNE 2024

(Amounts expressed in thousands of Turkish Lira ("TRL") in terms of the purchasing power of the TRL at June 30, 2025 unless otherwise indicated)

NOTE 26 – EVENTS AFTER THE REPORTING PERIOD

None.

…………..

Talk to a Data Expert

Have a question? We'll get back to you promptly.